THE DEPOSITARY RECEIPT

2015 Midyear Update

Pharmaceutical and biotech companies led the pack in terms of capital raisings through DRs in the first half of 2015. As of June 30, 2015, global DR offerings raised more than $3.8 billion. Our report shows that in the first half of 2015 81.6 billion DRs traded with a value of $1.57 trillion, up YoY 8.6% and 4.9% respectively. Also, 34 new programs were established in the first half of 2015.

Click to read the full report>>

NORTH AMERICAN INVESTORS' APPETITE FOR INDIAN EQUITIES

June 2015

As of 1H2015, North American investors represented a majority of institutional investment across every sector of India's private corporate economy. In this white paper, BNY Mellon assesses the attitudes of 32 active North American investors surveyed in early 2015 about their interest in Indian equities along with challenges in investing in the Indian market.


We also share the investors' recommendations for how Indian companies can improve their global investment appeal.

Click to read the full report>>

ENABLING INNOVATION

Discover how BNY Mellon helped broaden a surgical robotics company's investor base and capital markets reach.

"......In financial services, it is often difficult to see the results of your work. However, in this case, with Mazor, it was very easy."

Anthony Moro
Head of EMEA, Depositary Receipts


BNY Mellon was able to help Mazor Robotics raise capital through a Depositary Receipt program to realize its business goals for its revolutionary spinal surgery technology.

Click to see the story here.>>

Powered by Interactive Data Managed Solutions

© 2015 The Bank of New York Mellon Corporation. Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Quotes delayed at least 15 minutes.Market data provided by Interactive Data
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.